SEC Form 4 · accession 0000950138-18-000564
Elanco Animal Health Inc · ELAN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey N Simmons
Officer — Pres., Chief Executive Officer · Director
Period of report
Oct 20, 2018
Accepted (ET)
Oct 23, 2018 · 6:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001739104
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 20, 2018 | A | 36,287 | $0.00 | A | 58,287 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right-to-Buy)F2 | $31.61 | Oct 20, 2018 | A | 109,642 | A | — | Oct 20, 2028 | Elanco Animal Health Inc. Common Stock | 109,642 | 109,642 | D |
Explanation of responses
- F1Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021.
- F2Grant of stock option pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021.
Remarks
EXHIBIT LIST - Exhibit 24 - Power of Attorney for Jeffrey N. Simmons